|
|
| |
Mycophenolate Sodium Tablets 180 mg |
| |
For the prophylaxis of organ rejection in patients receiving allogeneic renal, cardiac or hepatic transplants.
|
| |
Adults : The recommended doses is 720 mg administered twice daily (1440 mg total daily dose) on an empty stomach, one hour before or two hours after food intake.
Pediatrics : Based on a pharmacokinetic study conducted in stable renal pediatric transplant patients, the recommended dose in stable pediatric patients is 400 mg/m² body surface area (BSA) administered twice daily (up to a maximum dose of 720 mg administered twice daily). Patients with a BSA of 1.19 to 1.58 m² may be dosed either with three 180 mg tablets or one 180 mg plus one 360 mg tablet twice daily (1080 mg daily dose).
Dosage Adjustment :
Renal Impairment : Not required.
Hepatic Impairment : May be required in renal patients with some hepatic diseases. |
| |
Packing : |
6 Strips of 10 Tablets |
|
|
